Salesforce Announces Timing of its Fourth Quarter and Full Year Fiscal 2025 Results Conference Call

Salesforce (NYSE: CRM) has announced the timing for its fourth quarter and full year fiscal 2025 financial results release.

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Tags

conferences earnings

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

02/05/2025 - 04:01 PM EST

Results to be released on Feb. 26, 2025, after market close

SAN FRANCISCO--(BUSINESS WIRE)-- Salesforce (NYSE: CRM), the #1 AI CRM, today announced that its fourth quarter and full year fiscal 2025 results will be released on Wednesday, Feb. 26, 2025, after the close of the market. The company will host a conference call at 2:00 p.m. (PT) / 5:00 p.m. (ET) to discuss its financial results with the investment community. A live webcast and replay of the event will be available on the Salesforce Investor Relations website at www.salesforce.com/investor.

About Salesforce

Salesforce helps organizations of any size reimagine their business with AI. Agentforce — the first digital labor solution for enterprises — seamlessly integrates with Customer 360 applications, Data Cloud, and Einstein AI to create a limitless workforce, bringing humans and agents together to deliver customer success on a single, trusted platform.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250205446550/en/

Mike Spencer
Salesforce
Investor Relations
investor@salesforce.com

Carolyn Guss
Salesforce
Public Relations
pr@salesforce.com

Source: Salesforce

Keep reading

More on CRM

All CRM news

Trending in the feed

EDSA

Edesa Biotech Announces Agreement with KYORIN Pharmaceutical to Develop and Commercialize Paridiprubart in Japan Open the live feed

From our desk

Braze Acquisition: Salesforce Agrees to Pay $47.50 a Share in Cash